Dolutegravir Sodium
1 NDC across 1 manufacturer|0 Generic,1 Brand
Dolutegravir Sodium is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 12, 2013. In 2024, Medicare Part D spent $629 million on Dolutegravir Sodium across 256,000 claims for 29,000 beneficiaries.
Dolutegravir Sodium is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $77.59 to $77.59 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$77.59 – $77.59
per EA
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DOLUTEGRAVIR SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TIVICAY 50 MG TABLET | $77.5916 per EA | -0.02% |
Frequently Asked Questions
What is Dolutegravir Sodium used to treat?
Dolutegravir Sodium is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Dolutegravir Sodium?
In 2024, Medicare Part D spent $629 million on Dolutegravir Sodium across 256,000 claims for 29,000 beneficiaries.
How many Dolutegravir Sodium products are on the market?
The Dolutegravir Sodium drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Dolutegravir Sodium?
NADAC reference prices for Dolutegravir Sodium range from $77.5916 to $77.5916 per EA.
Which manufacturers make Dolutegravir Sodium?
1 manufacturer lists Dolutegravir Sodium in NADAC. Ranked by number of NDCs, the largest are ViiV Healthcare Company (1).
How has the price of Dolutegravir Sodium changed recently?
Over the past 7 days, 0 Dolutegravir Sodium NDCs rose and 1 fell, with a market-wide average change of -0.0%.